“…In addition, there is debate concerning the levels of PSA, PSAD and PSA velocity which can be found following treatment, with several authors contending that PSA levels may be artificially raised during therapy, but are then likely to decline. [326][327][328][329][330] Poor outcome has been suggested in men with a PSA level greater than 4 ng/ml between 6 months and 5 years after radiotherapy. 330 It has been claimed that outcome following radiotherapy is equal to that of radical prostatectomy at Conformal radiotherapy involves the use of 3-D computer-assisted tomography to allow a more accurately directed beam configuration.…”
The editors have tried to ensure the accuracy of this report but cannot accept responsibility for any errors or omissions. They would like to thank the referees for their constructive comments on the draft document.
“…In addition, there is debate concerning the levels of PSA, PSAD and PSA velocity which can be found following treatment, with several authors contending that PSA levels may be artificially raised during therapy, but are then likely to decline. [326][327][328][329][330] Poor outcome has been suggested in men with a PSA level greater than 4 ng/ml between 6 months and 5 years after radiotherapy. 330 It has been claimed that outcome following radiotherapy is equal to that of radical prostatectomy at Conformal radiotherapy involves the use of 3-D computer-assisted tomography to allow a more accurately directed beam configuration.…”
The editors have tried to ensure the accuracy of this report but cannot accept responsibility for any errors or omissions. They would like to thank the referees for their constructive comments on the draft document.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.